Further, when they combined their signature with the pancreatic cancer marker CA19-9, the liquid biopsy test accurately detected 97% of stage 1-2 pancreatic cancers in the U.S. cohort. Stage 1 ...

A biomarker known as CA19-9 is commonly used to identify the presence of pancreatic cancer. However, the test for the presence of this marker is not accurate enough to detect early lesions or stage 1 ...